Continuous manufacturing of cell product for cell therapy

Goals

• Improvement of patients starting material
• Definition/Selection of target parameter
• Optimization of the perfusion process
• Analytical implementation of transcriptomics and proteomics
• Set-up of an automated system
• Implementation of on-line monitoring
• Reduction of manual operation

Project leaders

• Pontus Blomberg, KI

Partners